Related Experiment Video
Updated: May 24, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Heart failure treated with low-dose milrinone in a full-term newborn
S Sebková1, V Tomek, P Zemanová
1Department of Neonatology, Thomayer Hospital, Prague, Czech Republic.
Prague Medical Report
|March 1, 2012
Summary
Low-dose milrinone effectively treated a newborn with heart failure and persistent pulmonary hypertension. This phosphodiesterase III inhibitor improved cardiac function and oxygenation, showing promise for neonatal critical care.
Area of Science:
- Neonatal Cardiology
- Pediatric Pharmacology
Background:
- Persistent pulmonary hypertension of the newborn (PPHN) is a critical condition.
- Hypocontractile myocardium can complicate PPHN, leading to heart failure.
Observation:
- A term newborn presented with severe PPHN (Oxygenation Index 28) and heart failure (LVEF 35%, LS 18%).
- Treatment with low-dose milrinone was initiated.
Findings:
- Milrinone administration rapidly improved the infant's condition.
- Oxygenation Index decreased to 3 within 6 hours.
- Left ventricular ejection fraction (LVEF) and left ventricular shortening fraction (LS) improved to 57% and 30%, respectively.
Implications:
- Low-dose milrinone demonstrates potential as a safe and effective treatment for neonatal heart failure and PPHN.
- This approach may offer a novel therapeutic strategy in managing critically ill newborns.
- Further research is warranted to establish optimal dosing and long-term outcomes.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...